Enabling Precision Cancer Clinical Trials: A molecular profiling platform for the Australian clinical trials industry

To facilitate genomics testing and patient matching for clinical trials and focussed therapies the Garvan will engage at least 5 companies and have 250 tests conducted on a purpose built SME engagement platform.

This project will deliver a molecular profiling platform to increase capacity in Australia’s clinical trial sector, and increase the attractiveness of Australia to the international pharmaceutical industry. The platform includes a clinically-accredited molecular test for cancer trials, a genomics data platform to support clinical trials, and patient-matching capabilities to facilitate clinical trial recruitment.

Outcomes (FY2020):

• To date the project has trained over 400 individuals. 
• The project team has processed over 1,250 samples and engaged with six Australian-based SMEs including 4 clinical trials.
  
  

Visit Garvan Institute of Medical Research's website for more information.

Twitter: GarvanInstitute

LinkedIn: Garvan Institute of Medical Research